I feel for you there wegian. I started buying a few years back...

I feel for you there wegian. I started buying a few years back at 0.9-1c ( =10c post consol price) and have topped up repetitively between 4.5-5.5c over the past 6mths, and now have managed to average down to around 6.3c, I'm now running close to 50% of my overall portfolio in MLA, which shows my personal conviction to the stock and its prospects. Only time will tell whether this was a wise move!

IMO,  I could actually see a price of 12-20c arriving sooner than you think, IF (and thats a reasonably sized 'if') they can capitalise on underlying growth and margins in the human business, and  post around 800k-$1m for the FY15/16, PE of 15 @ a SP of 12c . This would need a couple great quarters, following this previous quarter's negative result due to carrying a cash hungry Medivet. A couple larger lumpy orders mainting a 50% margin could boost this higher.

all IMO, DYOR etc.